Gene Expression Profiling of Gliomas for Personalized Therapy
Author Information
Author(s): Vitucci M, Hayes D N, Miller C R
Primary Institution: University of North Carolina School of Medicine
Hypothesis
Can gene expression profiling improve the classification and treatment of gliomas?
Conclusion
Gene expression profiling has revealed significant molecular heterogeneity in gliomas, which may lead to more personalized treatment approaches.
Supporting Evidence
- Gene expression profiling has identified distinct molecular subtypes of gliomas.
- Studies show that molecular subtypes correlate with patient survival outcomes.
- Clinical trials are underway to evaluate the effectiveness of gene expression-based diagnostic tests.
Takeaway
Scientists are studying brain tumors called gliomas to find out how their genes work, which can help doctors give better treatments to patients.
Methodology
The study reviews a decade of gene expression profiling in gliomas, focusing on molecular subtypes and their prognostic implications.
Potential Biases
Potential bias due to the use of heterogeneous training sets and prior selection of outcome-related genes.
Limitations
Many studies used small sample sizes and lacked comprehensive multivariable analyses.
Participant Demographics
The study includes adult patients with newly diagnosed gliomas.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI: 6.9–13.0
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website